An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors
This study is currently recruiting participants.
Verified October 2012 by InnoPharmax Inc.
Sponsor:
InnoPharmax Inc.
Information provided by (Responsible Party):
InnoPharmax Inc.
ClinicalTrials.gov Identifier:
NCT01678690
First received: August 29, 2012
Last updated: October 26, 2012
Last verified: October 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | March 2013 |
| Estimated Primary Completion Date: | February 2013 (Final data collection date for primary outcome measure) |